KOSPI · Healthcare · ₩178B
₩9,560-1.75%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 3.9% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“원가 부담이 줄며 본업 회복의 첫발을 뗐어요.”
In the company's words · 2026 2분기 filing